These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2780258)

  • 1. Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments.
    De Peyer JE; Lues I; Gericke R; Häusler G
    Pflugers Arch; 1989; 414 Suppl 1():S191. PubMed ID: 2780258
    [No Abstract]   [Full Text] [Related]  

  • 2. Relaxation of human coronary artery and arteria mammaria by K(+)-channel openers.
    Bossaller C; Auch-Schwelk W; Graf K; Gräfe M; Catadelgirmen G; Ennker J; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S13-6. PubMed ID: 1282170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissues.
    BoSmith RE; Briggs I; Grant TL; Grimwood S; Russell NJ; Stone MA; Wickenden AD
    Pflugers Arch; 1989; 414 Suppl 1():S190. PubMed ID: 2506523
    [No Abstract]   [Full Text] [Related]  

  • 4. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
    Weston AH
    Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K+ channel openers suppress myotonic activity of human skeletal muscle in vitro.
    Quasthoff S; Spuler A; Spittelmeister W; Lehmann-Horn F; Grafe P
    Eur J Pharmacol; 1990 Sep; 186(1):125-8. PubMed ID: 2282934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K(+)-channel activators in vascular smooth muscle.
    Cox RH
    Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
    [No Abstract]   [Full Text] [Related]  

  • 8. Two different types of potassium channels in human skeletal muscle activated by potassium channel openers.
    Quasthoff S; Franke C; Hatt H; Richter-Turtur M
    Neurosci Lett; 1990 Nov; 119(2):191-4. PubMed ID: 2126363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.
    Sassen LM; Duncker DJ; Gho BC; Diekmann HW; Verdouw PD
    Br J Pharmacol; 1990 Nov; 101(3):605-14. PubMed ID: 2076480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and vasorelaxant activity of 2-fluoromethylbenzopyran potassium channel openers.
    Takahashi T; Koga H; Sato H; Ishizawa T; Taka N; Imagawa J
    Bioorg Med Chem; 1998 Mar; 6(3):323-37. PubMed ID: 9568286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat.
    Schilling L; Parsons AA; Wahl M
    J Neurosurg; 1995 Jul; 83(1):123-8. PubMed ID: 7782827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BRL 38227 on K-currents in rat portal vein.
    Edwards G; Noack T; Deitmer P; Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():336P. PubMed ID: 1507585
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
    Stockbridge N; Zhang H; Weir B
    Biochem Biophys Res Commun; 1991 Nov; 181(1):172-8. PubMed ID: 1958186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes.
    Pieper GM; Gross GJ
    Immunopharmacology; 1992; 23(3):191-7. PubMed ID: 1323556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SR 44866, a potassium channel opener, on action potentials of rabbit, guinea pig, and human heart fibers.
    Gautier P; Bertrand JP; Guiraudou P
    J Cardiovasc Pharmacol; 1991 May; 17(5):692-700. PubMed ID: 1713982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent and BRL 34915-induced vasodilatation in rat isolated perfused mesenteric arteries: role of G-proteins, K+ and calcium channels.
    Adeagbo AS; Malik KU
    Br J Pharmacol; 1990 Jul; 100(3):427-34. PubMed ID: 2167732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery.
    Russell SN; Smirnov SV; Aaronson PI
    Br J Pharmacol; 1992 Mar; 105(3):549-56. PubMed ID: 1628142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ATP-sensitive K+ channels by ATP and nucleotide diphosphate in rabbit portal vein.
    Kamouchi M; Kitamura K
    Am J Physiol; 1994 May; 266(5 Pt 2):H1687-98. PubMed ID: 8203568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.